Journal
FERTILITY AND STERILITY
Volume 81, Issue 5, Pages 1357-1365Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2003.09.073
Keywords
sperm motility; spermicidal activity; microbicide; vaginal contraceptive
Categories
Ask authors/readers for more resources
Objective: To evaluate the safety and contraceptive efficacy of magainin-A in monkeys. Design: Controlled laboratory study. Setting: Department of Immunology, National Institute for Research in Reproductive Health, Parel, Mumbai, India. Animal(s): Male and female bonnet monkeys (Macaca radiata). Intervention(s): Animals were treated intravaginally with 1 mg of magainin-A before attempted conception, as well as daily for 14 days to assess local and systemic toxicity. Main Outcome Measure(s): Suitability of magainin-A for the control of pregnancy and sexually transmitted infections. Result(s): Complete sperm immobilization was observed within 20 seconds after the exposure to magainin-A (800-1,000 mug) in vitro. Intravaginal administration of 1 mg of magainin-A blocked conception in monkeys. When magainin-A was administered intravaginally for 14 consecutive days, no treatment-related abnormalities were observed in menstrual cycle length, vaginal epithelial cell morphology, and hematologic/serum biochemical profiles. The peptide inhibited the growth of sexually transmitted infection-causing pathogens but not HIV-1 and HIV-2. Conclusion(s): Magainin-A can be used as an effective and safe intravaginal contraceptive compound with additional protection against sexually transmitted infection-causing pathogens.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available